Bitcoin (BTC) traders reacted positively to the latest policy announcement from the US Federal Reserve.

Despite jacking rates up another 25 basis points (bps) to 5.25%, comments from the Fed pointed to a loosening of its grip on the economy, boding well for riskier assets such as bitcoin.

Price action was generally positive, with BTC/USDT adding 1.2% to close Wednesday just above US$29,000, where selling resistance was largely placed.

Another 0.2% was sprinkled onto the pair in the mornings Asia trading session, pushing bitcoin closer to US$29,100.

Also buoyed by a depressed greenback, Ethereum (ETH) managed to add 1.9% on Wednesday, pushing the ETH/USDT pair just above the critical US$1,900 price point.

Today has been a bit muted for the pair, having dipped just below the US$1.9k mark again.

#ProactiveInvestors #CryptoReport #Bitcoin #ethereum #federalreserve #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Christina Lake Cannabis (CLC) CEO Mark Aiken tells Proactive's Stephen Gunnion the company has been able to weather market compression in the Canadian cannabis market due to strong growth in shipments of its industry-leading distillate.

Aiken discusses the company's first-quarter results, which revealed a 16% rise in revenue, and its plans to diversify with the introduction of more products, including pre-rolls, infused pre-rolls, kief, hash and infused hash.

CLC is also expanding into the international market, having recently signed an agreement to manufacture custom formulations for South African medical cannabis company African.

#ProactiveInvestors #ChristinaLakeCannabis #cannabisindustry #cannabisbusiness #cannabisproducts #distillates #growers #extractors #cannabisgrowers #cannabisextractors #cannabiscommunity #medicalcannabis #CBDproducts #THCproducts #Canadiancannabis #cannabisculture #cannabisinvesting #cannabisstocks #marijuanaindustry #marijuanabusiness #cannabisopportunities #cannabisdiversification #AfricanCannabis #SouthAfricancannabis #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Compugen Ltd CEO Anat Cohen-Dayag tells Proactive's Stephen Gunnion about the drug discovery company focused on cancer immunotherapy using the predictive power of its unique computational discovery approach.

Cohen-Dayag explains that Compugen is advancing new therapeutics and optimizing their combination to expand immuno-oncology treatment options to cancer patients who are refractory or unresponsive to currently available drugs.

However, she says the company faces the challenge of proving the validity of its pioneering discoveries.

#ProactiveInvestors #Compugen #CancerImmunotherapy #ComputationalDiscovery #DrugDiscovery #DinhamAxis #NewTreatmentSolutions #PioneersInMedicine #ClinicalStudies #OvarianCancer #ColorectalCancer #MedicalResearch #HealthcareInnovation #CancerTreatment #PrecisionMedicine #PatientCare #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Thomas Warner from Proactive after releasing new clinical trial data for the biotechnology company's IMU-856 molecule, which is aimed at restoring healthy gut function.

The molecule has shown promise in treating celiac disease, with potential applications for other gastrointestinal disorders such as Crohn's disease and ulcerative colitis.

Immunic Inc. plans to conduct a Phase 2 clinical trial for IMU-856 in celiac disease patients and explore other potential applications, saying that the phase 1b results "clearly go beyond" initial expectations.

#ProactiveInvestors #Immunic #IMU856 #celiacdisease #Crohnsdisease #ulcerativecolitis #guthealth #clinicaltrial #biomarkers #histology #healthcare #pharmaceuticals #medicine #treatment #immunesystem #nutrientabsorption #digestivehealth #healthresearch #medicalbreakthrough #healthtech #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

PYX Resources Ltd (LSE:PYX, NSX:PYX) chief executive Oliver Hasler speaks to Proactive's Thomas Warner after releasing the premium zircon producer's first quarter production update.

Hasler reports an increase in mineral sands and zircon production, and expresses bullish sentiment about the near-term future of the market. He also highlights a ten-year extension to the company's Tisma mineral sands project in Kalimantan, Indonesia, which now runs until July 2032.

#ProactiveInvestors #PYXResources #mineralsands #zircon #rutile #ilmenite #miningindustry #investing #CEOinterview #marketupdate #resourceinvesting #mininginvesting #economicoutlook #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Voltaic Strategic Resources Ltd (ASX:VSR) chief executive Michael Walshe speaks to Thomas Warner from Proactive following the commencement of a maiden drill program at the early stage exploration company's Ti Tree Project's Andrada prospect.

Walshe gives an overview of what Voltaic is working to achieve across its projects across western Australia and Nevada, USA.

He adds that the company prides itself on its technical team and is "unique in the micro-cap space" that its targeting.

#ProactiveInvestors #VoltaicStrategicResources #ExplorationCompany #CriticalMinerals #RareEarths #BatteryMetals #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

e-Therapeutics PLC (AIM:ETX OTCQX:ETXPF) CEO Ali Mortazavi speaks to Thomas Warner following the release of the computational biology and chemistry company's full year results for 2022.

Mortazavi says that it was a "tricky year for the biotechnology sector as a whole" but that eTherapeutics has shown "remarkable resilience."

He goes on to highlight the opportunity being presented to the company by the advent of large language models (LLMs) and GPT-4, saying that he's never before seen a technology "blindside the world" to such an extent.

#ProactiveInvestors #eTherapeutics #healthtech #computationalbiology #drugdiscovery #AI #machinelearning #GPT #largelanguagemodels #medicalresearch #precisionmedicine #healthcareinnovation #pharmaceuticals #biotech #dataanalytics #digitalhealth #healthcaretechnology #drugdevelopment #therapeutics #scientists #researchanddevelopment #clinicaltrials #medicalbreakthroughs #innovation #medicaltechnology #healthcareindustry #genomics #precisionhealthcare #patientcare #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Libertine Holdings PLC CEO Sam Cockerill joins Proactive's Stephen Gunnion from the Advanced Clean Transportation (ACT) Expo at the Anaheim Convention Center in California where the company is showcasing its HEXAGEN hermetic linear motor-generator technology for power generation and other applications.

Also at the ACT Expo, Cockerill says Hyliion’s KARNO technology is on public display for the first time.

Cockerill emphasizes the importance of renewable fuels, including green hydrogen and renewable natural gas, as a complement to battery electrification for reducing carbon emissions.

#ProactiveInvestors #LibertineHoldings #LSE #AIM #AdvancedCleanTransportExpo #ExogenTechnology #RenewableFuels #GreenHydrogen #HeavyDutyPowertrains #HermeticLinearMotorGenerator #ThermalEnergyStorage #HyliansKarnaTechnology #CarbonReduction #CleanTransportation #sustainablesolutions #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company was excited to be recognized as an Honorable mention in the Wellness category of Fast Company’s 2023 World Changing Ideas Awards.

Sobel telling Proactive this annual awards show looks for companies that show a desire for sustainable designs, innovative products, bold social initiatives, and other creative projects that are changing the world. The company was recognized for its work on the Flagship product Vinia, which has demonstrated in clinical trials the ability to increase dilation of arteries. The focused moving forward is scaling its Vinia business in North America, increasing its availability on platforms like Amazon and Walmart, and launching new products like functional coffee and dietary supplement protein bars in the next six to nine months.

#proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech #hearthealth

#Vinya #Wellness #Sustainability #HealthandWellness #Innovation #FastCompany #WorldChangingIdeas #ScalingUp #FunctionalCoffee #DietarySupplement #ProteinBars #HumanUtilityValue #RevenueGrowth #BreakEven #Amazon #Walmart#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive after releasing full year results for calendar year 2022 - a year he describes as "terrific" for the endoscopy-focused medical device company.

Gulliford also gives the highlights from the post-period, which included an oversubscribed £33.7mln gross fundraise in March of 2023, and says Creo "knows what [it] needs to do" moving forward.

#ProactiveInvestors #CREO #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews